Brain Fitness APP for Aging With a Healthy Brain
1 other identifier
interventional
33
1 country
1
Brief Summary
Memory and cognitive declines are associated with normal brain aging but are also precursors to dementia, in particular the so called the pandemic of the century, Alzheimer's disease. While currently there is no cure or "vaccine" against dementia, there are hopes to delay the onset of the disease by living a brain-healthy life style. The proposed research offers a novel approach to prevent dementia and age-related cognitive disorders. It is proposed to create a brain fitness APP for the aging population. The proposed APP is based on the premise of brain plasticity, and targets the brain functions that are declining with normal aging and dementia. The proposed APP will be tested on a large population with statistical rigor (60 healthy individuals of age 65+ years and up to 30 individuals with cognitive impairment); the participants will be divided into an intervention group and a control group. We will analyze the logged performance of the participants, and assess their cognitive state with an independent test compared to a matched control group before and after the trial. It is anticipated that the frequent use of the proposed APP will help to maintain a healthy brain as well as detecting the onset of a cognitive decline in aging population. In addition, its frequent use will slow and even reverse the progression of the cognition decline in individuals with mild cognitive impairment or dementia. The APP will have many different levels of difficulty so that it can be applied to a wide age range and conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 11, 2018
CompletedStudy Start
First participant enrolled
June 20, 2018
CompletedFirst Posted
Study publicly available on registry
July 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
April 10, 2019
CompletedFebruary 24, 2021
February 1, 2021
10 months
April 11, 2018
February 22, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
The change in Wechsler Memory Scale (WMS IV) from baseline
This assessment has a total of 11 tests, out of which we will use its six primary tests that assess our target brain functions, comprised of 12 subtests (subsections): Logical Memory 1, Verbal Paired Associates 1, Faces 1, Family Pictures 1, Logical Memory 2, Verbal Paired Associates 2, Faces 2, Family Pictures 2, Verbal Paired Associates 2 Recognition, Logical Memory 2 Recognition, Letter-Number Sequencing and Spatial Span. They are classified into 3 major memory indexes: Immediate Memory, General Memory and Working Memory. The WMS test is being purchased online from the following link; they do not provide a softcopy.
baseline, post-intervention within a week after the end of 4-week trial and a month after the second assessment
Secondary Outcomes (2)
Change in Egocentric Spatial Orientation
baseline, post-intervention within a week after the end of 4-week trial and a month after the second assessment
Change in MONTGOMERY ASBERG DEPRESSION RATING SCALE (MADRS)
baseline, post-intervention within a week after the end of 4-week trial and a month after the second assessment
Study Arms (2)
Active
EXPERIMENTAL4 weeks daily practice of the brain exercises
control
NO INTERVENTIONno brain exercises
Interventions
Eligibility Criteria
You may qualify if:
- MoCA ≥ 25
- Have no known or diagnosis of major depression, bipolar disorder, schizophrenia, mood disorder, Parkinson's disease, dementia of any type, or any other neurological degenerative disease.
- Capable of using an iPAD and access to Internet at home.
- Reading/writing fluency in English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Manitobalead
- AGE-WELL NCE Inc.collaborator
Study Sites (1)
Riverview Health Center
Winnipeg, Manitoba, R3L 2P4, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 11, 2018
First Posted
July 26, 2018
Study Start
June 20, 2018
Primary Completion
April 10, 2019
Study Completion
April 10, 2019
Last Updated
February 24, 2021
Record last verified: 2021-02